Vesanoid Market Set for Prominent Growth, Anticipated CAGR of 4.4% by 2030
Market Overview Vesanoid, also known as tretinoin, is a medication primarily used to treat acute promyelocytic leukemia (APL), a rare type of cancer that affects the blood and bone marrow. It is a form of vitamin A and works by inducing the maturation of immature blood cells, thereby preventing the progression of the disease. The Vesanoid market encompasses the production, distribution, and sales of this crucial drug, playing a vital role in the treatment and management of APL. The Vesanoid market is driven by the increasing prevalence of leukemia worldwide, particularly in developed countries. As awareness and diagnostic techniques improve,…
- Date: March 12, 2024
- Author: Timmy Thomas
- Category: PharmiWeb